Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

Q: What does CUSIP 03168L105 represent in this 13F holders report?

CUSIP 03168L105 is the security identifier for AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 used to aggregate holder disclosures.

Q: How many institutions held AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 in Q2 2019?

116 institutional investors reported AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 for Q2 2019. Use the holders table for investor-level position and value details.

CUSIP: 03168L105

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / Class A Common Stock, par value $0.01
Shares outstanding: 313,041,907
Total 13F shares: 105,380,317
Share change: -3,351,188
Total reported value: $755,561,286
Put/Call ratio: 62%
Price per share: $7.17
Number of holders: 116
Value change: -$88,067,679
Number of buys: 62
Number of sells: 87

Quarterly Holders Quick Answers

What is CUSIP 03168L105?
CUSIP 03168L105 identifies AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 03168L105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	6.3%	19,861,418	$281,436,000	—	31 Mar 2019	13F
Fosun International Ltd	13F	Company	6.2%	19,552,001	$277,052,000	—	31 Mar 2019	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	5.1%	15,907,280	$225,406,000	—	31 Mar 2019	13F
VANGUARD GROUP INC	13F	Company	3%	9,539,131	$135,169,000	—	31 Mar 2019	13F
FMR LLC	13F	Company	2.3%	7,295,225	$103,373,000	—	31 Mar 2019	13F
BlackRock Finance, Inc.	13F	Company	1.9%	5,845,706	$82,835,000	—	31 Mar 2019	13F
TPG Group Holdings (SBS) Advisors, Inc.	13F	Company	1.2%	3,884,600	$55,045,000	—	31 Mar 2019	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.76%	2,382,283	$33,757,000	—	31 Mar 2019	13F
TCW GROUP INC	13F	Company	0.74%	2,302,363	$32,625,000	—	31 Mar 2019	13F
STATE STREET CORP	13F	Company	0.62%	1,940,492	$27,497,000	—	31 Mar 2019	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.58%	1,826,285	$25,876,000	—	31 Mar 2019	13F
GW&K Investment Management, LLC	13F	Company	0.58%	1,805,274	$25,581,000	—	31 Mar 2019	13F
Neuberger Berman Group LLC	13F	Company	0.55%	1,709,999	$24,227,000	—	31 Mar 2019	13F
NORGES BANK	13F	Company	0.43%	1,348,373	$19,107,000	—	31 Mar 2019	13F
NORTHERN TRUST CORP	13F	Company	0.38%	1,185,777	$16,802,000	—	31 Mar 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.3%	953,580	$13,512,000	—	31 Mar 2019	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	0.26%	800,781	$11,347,000	—	31 Mar 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.21%	672,585	$9,531,000	—	31 Mar 2019	13F
STIFEL FINANCIAL CORP	13F	Company	0.19%	587,615	$8,299,000	—	31 Mar 2019	13F
MARSHALL WACE, LLP	13F	Company	0.16%	492,275	$6,977,000	—	31 Mar 2019	13F
Bank of New York Mellon Corp	13F	Company	0.16%	485,973	$6,887,000	—	31 Mar 2019	13F
TD ASSET MANAGEMENT INC	13F	Company	0.15%	482,175	$6,832,000	—	31 Mar 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.15%	479,057	$6,788,000	—	31 Mar 2019	13F
D. E. Shaw & Co., Inc.	13F	Company	0.14%	423,980	$6,008,000	—	31 Mar 2019	13F
Alyeska Investment Group, L.P.	13F	Company	0.13%	395,356	$5,602,000	—	31 Mar 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.12%	387,400	$5,489,000	—	31 Mar 2019	13F
Phocas Financial Corp.	13F	Company	0.12%	376,213	$5,331,000	—	31 Mar 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.12%	370,669	$5,253,000	—	31 Mar 2019	13F
Spark Investment Management LLC	13F	Company	0.11%	359,600	$5,095,000	—	31 Mar 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.11%	338,834	$4,802,000	—	31 Mar 2019	13F
Squarepoint Ops LLC	13F	Company	0.09%	286,808	$4,064,000	—	31 Mar 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.08%	261,416	$3,702,000	—	31 Mar 2019	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.08%	235,700	$3,340,000	—	31 Mar 2019	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.07%	209,421	$2,967,000	—	31 Mar 2019	13F
TEACHERS ADVISORS, LLC	13F	Company	0.06%	184,736	$2,618,000	—	31 Mar 2019	13F
Swiss National Bank	13F	Company	0.05%	167,600	$2,375,000	—	31 Mar 2019	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.05%	163,245	$2,313,000	—	31 Mar 2019	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.04%	133,093	$1,886,000	—	31 Mar 2019	13F
CREDIT SUISSE AG/	13F	Company	0.04%	132,460	$1,877,000	—	31 Mar 2019	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.04%	128,121	$1,815,000	—	31 Mar 2019	13F
ICON ADVISERS INC/CO	13F	Company	0.04%	128,042	$1,814,000	—	31 Mar 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.04%	126,049	$1,786,000	—	31 Mar 2019	13F
ROYAL BANK OF CANADA	13F	Company	0.04%	124,082	$1,759,000	—	31 Mar 2019	13F
RHUMBLINE ADVISERS	13F	Company	0.04%	123,850	$1,755,000	—	31 Mar 2019	13F
ARGENT CAPITAL MANAGEMENT LLC	13F	Company	0.04%	121,445	$1,721,000	—	31 Mar 2019	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.03%	108,616	$1,539,000	—	31 Mar 2019	13F
UNITED SERVICES AUTOMOBILE ASSOCIATION	13F	Company	0.03%	106,827	$1,514,000	—	31 Mar 2019	13F
Allianz Asset Management GmbH	13F	Company	0.03%	101,799	$1,442,000	—	31 Mar 2019	13F
Bellevue Group AG	13F	Company	0.03%	100,000	$1,417,000	—	31 Mar 2019	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.03%	94,505	$1,339,000	—	31 Mar 2019	13F

Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q2 2019

As of 30 Jun 2019, Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) was held by 116 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 105,380,317 shares. The largest 10 holders included Fosun International Ltd, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., TPG Group Holdings (SBS) Advisors, Inc., Point72 Asset Management, L.P., Neuberger Berman Group LLC, and STATE STREET CORP. This page lists 116 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

150

Q2 2019 holders

116

Holder diff

-34

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 Value $	Q2 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.